Downstream signaling pathways initiated by S1PR2 also play a role in multiple sclerosis, fibrosis, and inflammation.67 Our protein docking analyses revealed that fingolimod’s binding mode to S1PR2 is highly homologous to that of S1P. This evidence concerns the gene S1PR2 and multiple sclerosis.